Who Paid My Doc
A Phase 3, Multicenter, Open-Label Extension Study
Research payments
$847,151
Through program year 2022, $847,151 in research payments was reported against A Phase 3, Multicenter, Open-Label Extension Study, across 106 payments, paid by Celgene Corporation.
- Paid by
- Celgene Corporation
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | Research | $248,227 | 28 |
| 2021 | Research | $598,925 | 78 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Douglas Wolf Atlanta, GA Named on 3 payments
- John Gancayco Fort Sam Houston, TX Named on 2 payments
- Nir Modiano Portland, OR Named on 2 payments
- Nirmal Kaur Novi, MI Named on 2 payments
- Eugenia Shmidt Minneapolis, MN Named on 2 payments
- Sarah Sheibani Los Angeles, CA Named on 2 payments
- Jeffery Lewis Atlanta, GA Named on 2 payments
- Bryan Heath New Smyrna Beach, FL Named on 2 payments
- Kamran Ayub Oak Lawn, IL Named on 2 payments
- Salam Zakko Bristol, CT Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.